Nasdaq BioPharma Giant Invests $212M in Rain Tokens, Signaling Crypto Mainstream Adoption

A landmark move in the cryptocurrency world, Nasdaq-listed biopharmaceutical company Enlivex has announced a stunning $212 million investment in Rain tokens. This significant investment by a publicly traded firm represents one of the largest institutional bets on crypto assets to date and signals the growing mainstream acceptance of digital currencies. Enlivex’s strategic move follows closely on the heels of the launch of Rain Protocol, a prediction market platform that leverages blockchain technology for decentralized forecasting of real-world events.